Alger Health Sciences Fund
Alger Health Sciences Fund reported 71 holdings worth US$75.4M as of Jul 31, 2026 (Form N-PORT)
As of Jul 31, 2026 · Filed Sep 25, 2026
Alger Health Sciences Fund reported 71 holdings worth US$75.4M as of Jul 31, 2026. Largest: Merck & Company, Inc., Welltower Inc. and Johnson & Johnson. Filed Sep 25, 2026 (Form N-PORT).
- Holdings
- 71
- Value as reported
- US$75.4M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Merck & Company, Inc. | 24,176 | US$3.15M | 4.2% |
| Welltower Inc. | 13,242 | US$3.1M | 4.1% |
| Johnson & Johnson | 11,933 | US$3.06M | 4.1% |
| Thermo Fisher Scientific Inc | 5,248 | US$3.01M | 4.0% |
| Bruker Corporation | 47,717 | US$3M | 4.0% |
| Illumina, Inc. | 14,514 | US$2.98M | 4.0% |
| Cvs Health Corporation | 26,479 | US$2.77M | 3.7% |
| Unitedhealth Group Incorporated | 6,561 | US$2.72M | 3.6% |
| Teva Pharmaceutical Industries Limited | 76,047 | US$2.66M | 3.5% |
| Eli Lilly And Company | 2,155 | US$2.48M | 3.3% |
| Abbott Laboratories | 20,875 | US$2.21M | 2.9% |
| 10x Genomics, Inc. | 36,049 | US$1.7M | 2.3% |
| Novo Nordisk A/s Class B | 36,369 | US$1.69M | 2.2% |
| Repligen Corporation | 11,837 | US$1.67M | 2.2% |
| Royalty Pharma Plc | 24,966 | US$1.46M | 1.9% |
| Centene Corporation | 23,120 | US$1.44M | 1.9% |
| Incyte Corporation | 11,755 | US$1.4M | 1.9% |
| The Pennant Group, Inc. | 34,266 | US$1.38M | 1.8% |
| Arrowhead Pharmaceuticals, Inc. | 16,146 | US$1.37M | 1.8% |
| Guardant Health, Inc. | 8,425 | US$1.36M | 1.8% |
| Vertex Pharmaceuticals Incorporated | 2,840 | US$1.35M | 1.8% |
| Corteva, Inc. | 15,795 | US$1.24M | 1.6% |
| Abivax Sa | 9,738 | US$1.22M | 1.6% |
| Amgen Inc. | 2,800 | US$1.08M | 1.4% |
| Encompass Health Corporation | 9,591 | US$1.07M | 1.4% |
| Abbvie Inc. | 4,200 | US$1.05M | 1.4% |
| Sandoz Group Ltd | 11,690 | US$953K | 1.3% |
| Adaptive Biotechnologies Corporation | 36,621 | US$827K | 1.1% |
| Dianthus Therapeutics, Inc. | 7,466 | US$798K | 1.1% |
| Artivion, Inc. | 27,113 | US$727K | 0.97% |
| Cardinal Health, Inc. | 3,111 | US$716K | 0.95% |
| Waters Corporation | 1,885 | US$711K | 0.94% |
| Irhythm Holdings, Inc. | 6,061 | US$710K | 0.94% |
| Biogen Inc. | 3,456 | US$701K | 0.93% |
| Butterfly Network, Inc. | 97,812 | US$695K | 0.92% |
| American Healthcare Reit, Inc. | 12,303 | US$684K | 0.91% |
| Twist Bioscience Corporation | 7,413 | US$679K | 0.90% |
| Roivant Sciences Ltd. | 19,676 | US$667K | 0.89% |
| Spyre Therapeutics, Inc. | 6,726 | US$661K | 0.88% |
| Natera, Inc. | 2,414 | US$646K | 0.86% |
| Ligand Pharmaceuticals Incorporated | 2,142 | US$616K | 0.82% |
| Moderna, Inc. | 10,718 | US$588K | 0.78% |
| Erasca, Inc. | 32,291 | US$586K | 0.78% |
| Acadia Healthcare Company, Inc. | 15,375 | US$455K | 0.60% |
| Oscar Health, Inc. | 13,419 | US$419K | 0.56% |
| Revolution Medicines, Inc. | 1,908 | US$358K | 0.47% |
| Cogent Biosciences, Inc. | 8,752 | US$341K | 0.45% |
| Heartflow, Inc. | 10,966 | US$277K | 0.37% |
| Biomarin Pharmaceutical Inc. | 3,478 | US$209K | 0.28% |
| Janus Living, Inc. | 2,421 | US$73,138 | 0.10% |
| Edwards Lifesciences Corporation | 736 | US$63,348 | 0.08% |
| Celldex Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Vaxcyte, Inc. | 0 | US$0 | 0.00% |
| Mckesson Corporation | 0 | US$0 | 0.00% |
| Gilead Sciences, Inc. | 0 | US$0 | 0.00% |
| Integer Holdings Corporation | 0 | US$0 | 0.00% |
| Gsk Plc | 0 | US$0 | 0.00% |
| Hca Healthcare, Inc. | 0 | US$0 | 0.00% |
| United Therapeutics Corporation | 0 | US$0 | 0.00% |
| Forte Biosciences, Inc. | 0 | US$0 | 0.00% |
| Tg Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Intuitive Surgical, Inc. | 0 | US$0 | 0.00% |
| Boston Scientific Corporation | 0 | US$0 | 0.00% |
| Icu Medical, Inc. | 0 | US$0 | 0.00% |
| Celcuity Inc. | 0 | US$0 | 0.00% |
| Biocryst Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Brookdale Senior Living Inc. | 0 | US$0 | 0.00% |
| Nektar Therapeutics | 0 | US$0 | 0.00% |
| Summit Therapeutics Inc. | 0 | US$0 | 0.00% |
| Axogen, Inc. | 0 | US$0 | 0.00% |
| Astrazeneca Plc | 0 | US$0 | 0.00% |
Source
View original at SEC
Related